Appian Receives 2019 Technology Alliance Partner Award from Blue Prism
RESTON, Va., May 28, 2019 (GLOBE NEWSWIRE) -- Appian (NASDAQ: APPN) today announced it received Blue Prism’s 2019 Technology Alliance Program Premier Partner award at Blue Prism World 2019 in Orlando, FL. The combination of Appian’s low-code application platform with robotic process automation (RPA) from Blue Prism drives rapid deployment of intelligent automation solutions that optimize customer experience and operational performance.
“We’ve built a community of intelligent automation pioneers, innovators and partners at Blue Prism,” said Linda Dotts, SVP Global Partner Strategy and Programs for Blue Prism. “This community is our lifeblood, which enables us to deliver one of the most versatile and successful digital workforces on the planet. Congratulations to Appian for showing us what’s possible and for making Blue Prism truly the sum of our parts.”
The Blue Prism Technology Alliance Program (TAP) exemplifies a joint engineering approach with the world’s most innovative companies that augments Blue Prism’s digital workforce with deep technology partnerships promoting business transformation. Appian’s low-code platform delivers high-impact business applications up to 20 times faster. Appian’s powerful business process management (BPM) and case management capabilities make it easy to orchestrate complete processes and ensure effective collaboration across the modern workforce of people, robots, and artificial intelligence (AI).
Appian recently announced its new Robotic Workforce Manager solution for Blue Prism that enhances visibility into robotic processes, and gives human workers greater control over when and how to invoke, prioritize, and coordinate work with digital workers. At the same time, Appian released a series of no-code integration plug-ins for designers and administrators in the Blue Prism environment. Called “Appian Skills,” they are drag-and-drop integrations that make it easy for Blue Prism developers to connect with Appian.
Prittam Bagani, Director of Product Strategy at Appian, was on-hand to receive the award at Blue Prism World. He said, “The speed and efficiency that robots can deliver promises tremendous business value from front-line customer service to back-office processing. As more organizations adopt digital workforces, they realize the key to unlocking that value is optimizing how and when the robots are used to support human processes and interactions. Appian has a successful strategic relationship with Blue Prism that is focused on making that optimization easy. We are delighted to receive this recognition and thank Blue Prism for this appreciation.”
At the recent Appian World 2019 conference in San Diego, organizations including Aegon, Unione Fiduciaria, Queensland University of Technology, and OCC discussed the benefits of combining Appian and Blue Prism. At Blue Prism World 2019, Appian and S&P Global presented a session on driving intelligent automation through the combination of both technologies. For more information on Appian RPA with Blue Prism, visit https://www.appian.com/platform/robotic-process-automation-rpa/.
Appian provides a low-code development platform that accelerates the creation of high-impact business applications. Many of the world’s largest organizations use Appian applications to improve customer experience, achieve operational excellence, and simplify global risk management and compliance. For more information, visit www.appian.com.
For Information Contact:
Nicole Greggs, Director of Media Relations, Appian
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Camunda Announces Extensive Speaker Lineup for CamundaCon 201924.6.2019 09:00:00 CEST | Pressemelding
Early Bird Tickets for the annual Camunda Community event available until June 30 BERLIN, June 24, 2019 (GLOBE NEWSWIRE) -- Camunda, an open source software company reinventing workflow automation, today announced the speaker lineup for its annual user conference – CamundaCon – featuring presenters from LinkedIn, Roche and AXA, among others. Demand for the tech-focused event is significantly outpacing last year and discounted Early Bird tickets are available only until June 30. CamundaCon, an event created for software developers, enterprise architects and IT executives who want to learn about workflow and decision automation, takes place September 12-13 in the heart of Berlin. It brings together workflow automation and BPMN experts, the global Camunda community and the Camunda engineering team to share best practices, discuss the product roadmap and get inspiration from fellow Camunda users. New this year to the annual conference is a developer-focussed track, with dedicated tutorials
ERYTECH Announces Opening of Operations at its New Princeton, NJ GMP Manufacturing Facility24.6.2019 07:30:00 CEST | Pressemelding
Inauguration event held last week to officially open 30,000 sq. ft GMP manufacturing facility constructed in Princeton, NJ to produce lead product candidate eryaspase in the United States PRINCETON, N.J. and CAMBRIDGE, Mass. and LYON, France, June 24, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, announced today the opening of its new Princeton, NJ GMP manufacturing facility. The facility will support production capacity needs for eryaspase, the Company’s lead product candidate for patients in the United States. Eryaspase is in Phase 3 clinical development for the treatment of second-line pancreatic cancer. The Phase 3 clinical trial, which is referred to as the Trybeca-1 trial is expected to enroll approximately 500 patients with second-line metastatic pancreatic cancer at approximately 120 clinical sites in Europe and the Unite
Minerva Neurosciences to Host Live Conference Call and Webcast With Key Opinion Leaders to Discuss Successful Insomnia Trial With Seltorexant23.6.2019 23:30:00 CEST | Pressemelding
Call scheduled for 8:30 a.m. Eastern Time on June 24 to review results of successful Phase 2b trial showing achievement of primary and secondary endpoints with potential first-in-class specific orexin-2 receptor antagonist for the treatment of insomnia Key Opinion Leaders, Dr. Thomas Roth and Dr. David Kupfer, to be joined by Dr. Remy Luthringer, Executive Chairman and CEO of Minerva WALTHAM, Mass., June 23, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, will host a live conference call and webcast tomorrow, June 24, 2019 to discuss the results of its successful Phase 2b clinical trial of seltorexant (MIN-202) in patients with insomnia disorder (see dial-in information below). The Company plans to issue a press release detailing top-line results prior to the call. Conference Call Information: Minerva Neurosciences will hold a conferen
GE Board of Directors Authorizes Regular Quarterly Dividend21.6.2019 19:35:00 CEST | Pressemelding
BOSTON, June 21, 2019 (GLOBE NEWSWIRE) -- The Board of Directors of GE (NYSE: GE) today declared a $0.01 per share dividend on the outstanding common stock of the Company. The dividend is payable July 25, 2019 to shareowners of record at the close of business on July 1, 2019. The ex-dividend date is June 28, 2019. About GE GE (NYSE:GE) drives the world forward by tackling its biggest challenges. By combining world-class engineering with software and analytics, GE helps the world work more efficiently, reliably, and safely. For more than 125 years, GE has invented the future of industry, and today it leads new paradigms in additive manufacturing, materials science, and data analytics. GE people are global, diverse and dedicated, operating with the highest integrity and passion to fulfill GE's mission and deliver for our customers. www.ge.com GE's Investor Relations website at www.ge.com/investor and our corporate blog at www.ge.com/reports and @GE_Reports on Twitter, as well as GE's Fac
Wildflower Featured in NetworkNewsWire Publication Summarizing Amazing Profits Found in Cannabis21.6.2019 14:30:00 CEST | Pressemelding
NEW YORK, June 21, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities. To view the full publication, titled “Searching for the Next Super Nova,” visit: http://nnw.fm/P7LFo. Quarter-over-quarter sales growth is one of the indicators used to target explosive upside potential. Similar growth patterns were exhibited by many of the cannabis behemoths prior to parabolic price increases. In what may be an equally telling indicator, Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) revenues have now increased 11 consecutive quarters, quarter on quarter, ever since the company started selling its hemp-based CBD products. Founded in 2012 as a private company, Wildflower Brands went public in 2014 and has been on a tear ever since. Wildflower is an integrated health-and-wellness company crea
Fortuna Reports Results of Annual General Meeting21.6.2019 11:00:00 CEST | Pressemelding
VANCOUVER, British Columbia, June 21, 2019 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) hereby announces the voting results at the Company’s annual general meeting held on June 20, 2019. A total of 106,646,841 common shares were represented at the meeting, being 66.58% of the Company’s issued and outstanding shares as at the record date. Shareholders voted in favour of all matters brought before the meeting including the appointment of auditors, and the election of management’s nominees as directors. Detailed results of the votes on the election of directors are as follows: Director Votes For Votes Withheld Jorge Ganoza Durant Simon Ridgway Mario Szotlender David Farrell David Laing Alfredo Sillau Kylie Dickson 68,615,628 (98.9%) 39,765,591 (57.3%) 67,659,125 (97.5%) 66,958,952 (96.5%) 68,280,736 (98.4%) 68,434,565 (98.7%) 68,393,226 (98.6%) 755,610 (1.1%) 29,605,647 (42.7%) 1,712,113 (2.5%) 2,412,286 (3.5%) 1,090,502 (1.6%) 936,673 (1.3%) 978,012 (1.4%) About F